Get started
Author

Diana Brewer

Maternal, Fetal, and Neonatal Imatinib Levels With Treatment of Chronic Myeloid Leukemia in Pregnancy
2017 · Richard M. Burwick, Kelly Kuo, et al. · Obstetrics and Gynecology · 23
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy
2024 · Christopher A. Eide, Diana Brewer, et al. · Cancer Cell · 19
PDF
Concurrent STAT3, DNMT3A, and TET2 mutations in T‐LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential
2016 · Philipp W. Raess, Michael J. Cascio, et al. · American Journal of Hematology · 18
PDF
Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
2021 · Brittany M. Smith, Diana Brewer, et al. · Case Reports in Oncology · 6
PDF
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report
2021 · Sarah A. Carratt, Diana Brewer, et al. · Biomarker Research · 3
PDF
BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia
2021 · Aaron M. Tsumura, Brian J. Druker, et al. · JCO Precision Oncology · 1
PDF
Outcomes and responsiveness of standard tyrosine kinase inhibitor dose versus dose de-escalation in chronic myeloid leukemia: A single-center retrospective study.
2026 · Mark Pusung, Christopher Eide, et al. · Journal of Clinical Oncology
Standard tyrosine kinase inhibitor dose versus dose de-escalation prior to treatment-free remission attempt in chronic myeloid leukemia: A single-center 25-year retrospective study
2025 · Mark Pusung, Christopher Eide, et al. · Blood
ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states
2025 · Lauren Banaszak, Bianca Barredo, et al. · Blood
PDF
Works count: 9
Citation count: 70
H-index: 4
I10-index: 3
Year
Topic
Type